Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
Physicians’ and Pharmacists’ Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study
Cost-effectiveness of lenalidomide in combination with dexamethasone compared to bortezomib in combination with dexamethasone for the second-line treatment of multiple myeloma in Chile
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature
Use of telemedicine in Spain – Perceptions of patients, physicians and pharmacists
The view of experts on initiatives to be undertaken to promote equityin the access to orphan drugs and specialised care for rare diseases inSpain: A Delphi consensus
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Patients’ and professionals’ preferences in terms of the attributes of home enteral nutrition products in Spain. A discrete choice experiment
El papel de la Evaluación de las Tecnologías Sanitarias (ETS) en la toma de decisiones sobre política farmacéutica
Cost-effectiveness of ruxolitinib vs. Best Available Therapy in the treatment of myelofibrosis in Spain
